Benchmark analyst Mark Palmer initiated coverage of ASST with a Buy rating and a $32 price target, as the stock traded 3.59% lower in pre-market activity.
Initiation Details
Palmer began coverage of ASST with a Buy recommendation and set a price target of $32. The initiation adds a new sell-side view to the stock’s coverage universe and outlines the analyst’s valuation framework for the shares.
Market Reaction
ASST shares were down 3.59% in pre-market trading following the note. Pre-market moves can reflect initial investor response to new research as well as broader market conditions ahead of the regular session.
What to Watch
- Any follow-up research or company updates that could clarify near-term catalysts
- Trading volumes and price action as the regular session opens
- Changes to consensus estimates and additional analyst commentary